Business context and reporting period
Identity and period mismatch: The supplied filing is Stratean, Inc.’s Form 10-K for the fiscal year ended September 30, 2015—not a CleanSpark, Inc. filing or a standalone 2015 Q4 report. Stratean was developing and testing a modular waste-to-energy gasifier, with plans to pursue licensing, manufacturing and direct sales. It reported no employees and relied on consultants.
Financial results and position
| Metric | FY ended Sep. 30, 2015 | FY ended Sep. 30, 2014 |
|---|---|---|
| Revenue | $0 | $2,555 |
| Gross profit | $0 | $1,855 |
| Operating expenses | $3,479,859 | $61,087 |
| Net loss | $3,485,003 | $45,145 |
| Cash from operations | $(190,661) | $(103,504) |
| Cash from investing | $(79,547) | $(3,525) |
| Cash from financing | $242,000 | $223,500 |
At September 30, 2015, cash was $88,533; current assets were $112,924; total assets were $817,399; current liabilities were $55,440; and working capital was $57,484. Notes payable were zero, down from $44,857 a year earlier. The filing reports no cash interest or tax payments. A gross margin for 2015 is not meaningful because revenue and cost of revenue were both zero.
Material changes versus the prior year
Revenue ceased, while operating expenses rose sharply, principally because of $3.24 million in stock-based consulting expense. The annual net loss increased to $3.49 million from $45,145. Operating cash use increased, cash declined by $28,208, and fixed assets rose to $657,647 from $580,973. Financing included $242,000 from common-stock and warrant placements; the company also settled $50,000 of notes by issuing shares.
Outlook, risks and unusual items
- Funding and going concern: Management said cash was insufficient to fund operations for the next 12 months and planned to seek private-equity financing. The auditor highlighted substantial doubt about the company’s ability to continue as a going concern; the financial statements contain no adjustments for that uncertainty.
- Development and commercialization: The gasifier remained under development; the company said a commercially viable unit was not expected to be sellable until around mid-2016. Preliminary tests conducted in November and December 2015 were described by management as exceeding expectations, despite minor conveyor and thermocouple issues. These were post-year-end preliminary results, not evidence of commercial performance.
- Execution and market risks: The company had no significant customer-sale negotiations and warned that failure to obtain customers would hurt results. It also cited competition, limited funds, uncertain development outcomes, and environmental and workplace regulation risks.
- Dilution and governance: Compensation included 1.5 million common shares and 7.5 million warrants to officers and directors; the filing valued stock-based consulting expense at $3.24 million overall. The 7,877,600 warrants outstanding at year-end had a reported weighted-average exercise price of $0.10. Series A preferred shares carried voting, dividend, liquidation and change-of-control rights. Disclosure controls and internal control over financial reporting were deemed ineffective, with material weaknesses in segregation of duties and written accounting policies.
- Other obligations: Debt-settlement agreements granted two holders royalties on gasifier-unit sales for ten years, totaling 0.75% of defined gross revenues. A gasifier testing agreement called for total payments of $147,144, with the final independent report anticipated by March 2016.
Important facts for investors to verify
- Confirm the filing is for Stratean, not CleanSpark, and that the intended period is fiscal 2015 rather than Q4 alone.
- Review the full audited statements and notes: the extracted statements are labeled “unaudited” despite the auditor’s opinion, and the MD&A’s revenue comparison refers to 2013 while the financial statements compare 2014.
- Reconcile share counts: the balance sheet reports 20,378,415 common shares at September 30, 2015, while the cover reports 20,368,415 as of December 7, 2015.
- Assess financing availability, cash runway, preferred-stock rights, warrant and option dilution, and the related-party royalties.
- Seek independent evidence of gasifier test results, commercial readiness, customer demand, manufacturing costs and regulatory compliance.